AGP Executive Report
Last update: 9 hours agoTaiwan Drug Safety: Taiwan’s Food and Drug Administration is rechecking contraceptives containing desogestrel and etonogestrel after the European Medicines Agency flagged a small increased meningioma risk with prolonged use, with a reassessment underway and a prior safety alert issued on Sept. 2. AI Governance: Ahead of the Sept. 24 Trump-Xi summit, the U.S. is pushing a new AI incident notification mechanism focused on national security, after preparatory talks in New York; China’s response remains unclear. Biotech & Clinical Trials: Antengene says the first patient has been dosed in China for its pivotal Phase III CLINCH-3 study of ATG-022, an antibody-drug conjugate for CLDN18.2+ advanced gastric/gastroesophageal junction cancer. Connected Healthcare Tech: FUJIFILM Australia appointed Tonia Nuttall to lead healthcare informatics, aiming to expand digital clinical workflows across Australia and New Zealand. Health Research: A new discussion highlights efforts to predict and intercept psoriatic arthritis early in people with psoriasis, noting current models and risk factors but limited precision. Local Incident: A man stabbed an employee at Fubon Life’s Taipei office before turning the knife on himself; both were rushed to hospital.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
